Navigation Links
Taking probiotics in pregnancy or giving them to infants doesn't prevent asthma

Taking probiotics has health benefits but preventing childhood asthma isn't one of them, shows newly published research led by medical scientists at the University of Alberta.

Meghan Azad, a Banting post-doctoral fellow in the Faculty of Medicine & Dentistry at the U of A, was the principal investigator on the findings that appeared in the British Medical Journal this week. Her team reviewed data from 20 clinical trials in Europe, Australia, New Zealand and Taiwan that involved more than 4,800 children whose mothers either took probiotics during pregnancy or gave probiotics to their babies in the first year. The rate of doctor-diagnosed asthma was 11.2 per cent amoung infants who received probiotics and 10.2 per cent amoung babies who received the placebo.

"Taking probiotics had no effect on the asthma rate," said Azad, who works in the Faculty's Department of Pediatrics. "We haven't shown there's any harm in giving probiotics, but it can't really be advised as a strategy to prevent asthma.

"That doesn't mean probiotics aren't good for other reasons. There's really good evidence that probiotics are beneficial to infants who are born pre-term and suffer from a bowel condition. There's also good evidence that probiotics might prevent eczema. Her team made another interesting finding that warrants more research: babies who received probiotics as infants or in utero had higher incidences of lower respiratory infections.

"This study identified a potential association between probiotics and lower respiratory infections," said Azad. "But more research is required to see if the two are indeed linked."

She thinks the topic of research was important because "it summarized an emerging area of research, and will help physicians make evidence-based decisions relating to childhood asthma prevention."

Azad's team included U of A colleagues Anita Kozyrskyj with the Faculty's Department of Pediatrics and Catherine Field with the Faculty of Agricultural, Life and Environmental Sciences. Colleagues from the University of Manitoba included: Clare Ramsey, Allan Becker, Ahmed M Abou-Setta, Carol Friesen and Ryan Zarychanski.

Azad is continuing her research in this general area, examining the use of antibiotics and how it impacts the microbiota of babies' guts.


Contact: Raquel Maurier
University of Alberta Faculty of Medicine & Dentistry

Related biology news :

1. An invasive Asian fly is taking over European fruit
2. Young researcher taking fight against global killer to the next level in Vietnam
3. Taking Americas rarest snake back to the woods
4. Taking a hit or 2
5. Taking the pulse of volcanoes using satellite images
6. Taking the gamble out of DNA sequencing
7. Study finds taking probiotics has benefits for patients in hospitals
8. Taking a cue from nature
9. Calcium and vitamin D improve bone density in patients taking antiepileptic drugs
10. Women prescribed combination HRT should use caution when taking apigenin supplement, MU study finds
11. Behind closed doors: Researchers show how probiotics boost plant immunity
Post Your Comments:
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology: